Influence of Ku86 and XRCC4 expression in uterine cervical cancer on the response to preoperative radiotherapy

Med Mol Morphol. 2016 Dec;49(4):210-216. doi: 10.1007/s00795-016-0136-5. Epub 2016 Feb 11.

Abstract

DNA double-strand breaks (DSB) are severe damages induced by ionizing radiation. Non-homologous end joining (NHEJ) is a major mechanism for repairing DSB. Immunohistochemical analysis of proteins involved in NHEJ, such as Ku86 and XRCC4 (X-ray repair cross-complementing protein 4) may be useful for predicting tumor radiosensitivity. We examined the relationship between expression of DSB-related proteins in biopsy specimens of uterine cervical cancer and the pathological effect of 40 Gy of preoperative radiotherapy. 119 patients with uterine cervical cancer were treated between 2000 and 2011. Pathological effects of preoperative radiotherapy were classified by examining hysterectomy specimens. Patients with complete response (pCR) had a significantly better overall 5-year survival rate than those without pCR (96.3 vs. 76.9 %, P = 0.02). The pCR rate was significantly higher in patients with low Ku86 and XRCC4 expression than in other patients (47.4 vs. 21.3 %, P = 0.04). Logistic regression analysis also demonstrated that low Ku86 and XRCC4 expression was a significant predictor of pCR (P = 0.03). Patients with high Ku86 and XRCC4 expression had a significantly lower 5-year metastasis-free rate than others (79.3 vs. 93.5 %, P = 0.02). Proteins involved with NHEJ might have an influence on results of radiotherapy for uterine cervical cancer.

Keywords: Immunohistochemical staining; Ku86; Radiotherapy; Uterine cervical cancer; XRCC4.

MeSH terms

  • Adult
  • Aged
  • Biopsy
  • Cell Count
  • DNA End-Joining Repair / genetics
  • DNA-Binding Proteins / metabolism*
  • Disease-Free Survival
  • Female
  • Humans
  • Ku Autoantigen / metabolism*
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Preoperative Care*
  • Treatment Outcome
  • Uterine Cervical Neoplasms / metabolism*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / surgery*

Substances

  • DNA-Binding Proteins
  • XRCC4 protein, human
  • XRCC5 protein, human
  • Ku Autoantigen